AU2018383915B9 - Multivalent feline vaccine - Google Patents

Multivalent feline vaccine Download PDF

Info

Publication number
AU2018383915B9
AU2018383915B9 AU2018383915A AU2018383915A AU2018383915B9 AU 2018383915 B9 AU2018383915 B9 AU 2018383915B9 AU 2018383915 A AU2018383915 A AU 2018383915A AU 2018383915 A AU2018383915 A AU 2018383915A AU 2018383915 B9 AU2018383915 B9 AU 2018383915B9
Authority
AU
Australia
Prior art keywords
feline
fcv
leu
ser
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018383915A
Other languages
English (en)
Other versions
AU2018383915A1 (en
AU2018383915B2 (en
Inventor
Rhonda Lafleur
Ian Tarpey
Zhichang Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of AU2018383915A1 publication Critical patent/AU2018383915A1/en
Priority to AU2022209359A priority Critical patent/AU2022209359B2/en
Publication of AU2018383915B2 publication Critical patent/AU2018383915B2/en
Application granted granted Critical
Publication of AU2018383915B9 publication Critical patent/AU2018383915B9/en
Priority to AU2025279721A priority patent/AU2025279721A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36141—Use of virus, viral particle or viral elements as a vector
    • C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2018383915A 2017-12-15 2018-11-05 Multivalent feline vaccine Active AU2018383915B9 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2022209359A AU2022209359B2 (en) 2017-12-15 2022-07-30 Multivalent feline vaccine
AU2025279721A AU2025279721A1 (en) 2017-12-15 2025-12-11 Multivalent feline vaccine

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762599401P 2017-12-15 2017-12-15
US62/599,401 2017-12-15
PCT/EP2018/080106 WO2019115090A1 (en) 2017-12-15 2018-11-05 Multivalent feline vaccine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2022209359A Division AU2022209359B2 (en) 2017-12-15 2022-07-30 Multivalent feline vaccine

Publications (3)

Publication Number Publication Date
AU2018383915A1 AU2018383915A1 (en) 2020-05-14
AU2018383915B2 AU2018383915B2 (en) 2023-05-25
AU2018383915B9 true AU2018383915B9 (en) 2023-06-01

Family

ID=64316488

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2018383915A Active AU2018383915B9 (en) 2017-12-15 2018-11-05 Multivalent feline vaccine
AU2022209359A Active AU2022209359B2 (en) 2017-12-15 2022-07-30 Multivalent feline vaccine
AU2025279721A Pending AU2025279721A1 (en) 2017-12-15 2025-12-11 Multivalent feline vaccine

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2022209359A Active AU2022209359B2 (en) 2017-12-15 2022-07-30 Multivalent feline vaccine
AU2025279721A Pending AU2025279721A1 (en) 2017-12-15 2025-12-11 Multivalent feline vaccine

Country Status (4)

Country Link
JP (3) JP7427585B2 (https=)
AU (3) AU2018383915B9 (https=)
CA (1) CA3080087A1 (https=)
WO (1) WO2019115090A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108473539B (zh) * 2015-12-23 2022-03-22 英特维特国际股份有限公司 猫杯状病毒疫苗
WO2021228731A1 (en) 2020-05-11 2021-11-18 Intervet International B.V. Feline severe acute respiratory syndrome coronavirus 2 vaccine
US20240000920A1 (en) 2020-11-12 2024-01-04 Intervet Inc. Recombinant vectors encoding chimeric coronavirus spike proteins and use thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066568A2 (en) * 2000-03-09 2001-09-13 Heska Corporation Use of recombinant antigens to determine the immune status of an animal
US9441247B2 (en) * 2004-05-18 2016-09-13 Alphavax, Inc. TC-83-derived alphavirus vectors, particles and methods
WO2017109045A1 (en) * 2015-12-23 2017-06-29 Intervet International B.V. Feline calicivirus vaccine
WO2019110213A1 (en) * 2017-12-08 2019-06-13 Intervet International B.V. Feline calicivirus vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03001680A (es) 2000-08-29 2004-11-01 Wyeth Corp Empaque de particulas de un replicon del virus de acido ribonucleico (arn) de hebra positiva.
US7309495B2 (en) 2003-03-14 2007-12-18 The Regents Of The University Of California Hemorrhagic feline calicivirus
US7306807B2 (en) 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
DK2947149T3 (en) 2007-06-21 2018-06-06 Alphavax Inc ALPHAVIRUS REPLICATION PARTICLES FOR USE IN VACCINATION
US10411152B2 (en) * 2016-06-27 2019-09-10 Merlin Solar Technologies, Inc. Solar cell bonding
JP7731670B2 (ja) * 2017-11-06 2025-09-01 インターベット インターナショナル ベー． フェー． ネコ白血病ウイルスワクチン

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066568A2 (en) * 2000-03-09 2001-09-13 Heska Corporation Use of recombinant antigens to determine the immune status of an animal
US9441247B2 (en) * 2004-05-18 2016-09-13 Alphavax, Inc. TC-83-derived alphavirus vectors, particles and methods
WO2017109045A1 (en) * 2015-12-23 2017-06-29 Intervet International B.V. Feline calicivirus vaccine
WO2019110213A1 (en) * 2017-12-08 2019-06-13 Intervet International B.V. Feline calicivirus vaccine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VANDER VEEN RYAN L; HARRIS D L HANK; KAMRUD KURT I: "Alphavirus replicon vaccines", ANIMAL HEALTH RESEARCH REVIEWS, CAB INTERNATIONAL ; CAMBRIDGE : CAMBRIDGE UNIVERSITY PRESS, UK, vol. 13, no. 1, 1 June 2012 (2012-06-01), UK , pages 1 - 9, XP009166113, ISSN: 1475-2654, DOI: 10.1017/S1466252312000011 *

Also Published As

Publication number Publication date
JP2025170230A (ja) 2025-11-18
JP2023179547A (ja) 2023-12-19
AU2018383915A1 (en) 2020-05-14
AU2018383915B2 (en) 2023-05-25
AU2025279721A1 (en) 2026-01-15
AU2022209359A1 (en) 2022-09-29
JP7742695B2 (ja) 2025-09-22
JP7427585B2 (ja) 2024-02-05
CA3080087A1 (en) 2019-06-20
AU2022209359B2 (en) 2025-10-16
WO2019115090A1 (en) 2019-06-20
JP2021506746A (ja) 2021-02-22

Similar Documents

Publication Publication Date Title
JP7742695B2 (ja) 多価ネコワクチン
JP7731670B2 (ja) ネコ白血病ウイルスワクチン
JP7721604B2 (ja) ネコカリシウイルスワクチン
AU2018360288B2 (en) Rabies virus vaccine
US20240398934A1 (en) Feline leukemia virus vaccine
US11730809B2 (en) Multivalent feline vaccine
RU2797538C2 (ru) Поливалентная вакцина для животных семейства кошачьих
RU2784533C2 (ru) Вакцина против вируса лейкоза кошачьих
RU2792898C2 (ru) Вакцина против кошачьего калицивируса
RU2782350C2 (ru) Вакцина против вируса бешенства

Legal Events

Date Code Title Description
SREP Specification republished
FGA Letters patent sealed or granted (standard patent)